Inflammatory Bowel Diseases: From Bench to Bedside : Proceedings of the Falk Symposium No. 96 (Part IV of the Gastroenterology Symposia 1996) Held in Freiburg-im-Breisgau, Germany, October 30-November 1, 1996T. Andus |
From inside the book
Results 1-3 of 93
Page 22
... immune stimulation through any number of bacterial constituents that are known to activate immune cells . Although the gut mucosa is the interface between the immune system and the microbial environment , we know very little about how ...
... immune stimulation through any number of bacterial constituents that are known to activate immune cells . Although the gut mucosa is the interface between the immune system and the microbial environment , we know very little about how ...
Page 97
... IMMUNE RESPONSES The intestinal lumen contains high numbers of bacteria , dietary antigens and other agents . The local mucosal immune system in the gut , therefore , has to pro- tect the host against invasion of potential pathogens or ...
... IMMUNE RESPONSES The intestinal lumen contains high numbers of bacteria , dietary antigens and other agents . The local mucosal immune system in the gut , therefore , has to pro- tect the host against invasion of potential pathogens or ...
Page 167
... immune cells are capable of responding to a variety of neurotransmitters and that nerves them- selves are a target for the products of immune cells1 - 5 . These cells are also in close anatomical proximity6.7 . The biological ...
... immune cells are capable of responding to a variety of neurotransmitters and that nerves them- selves are a target for the products of immune cells1 - 5 . These cells are also in close anatomical proximity6.7 . The biological ...
Contents
new data | 5 |
Current and future parameters for stratification | 13 |
Genetic and chemical models of inflammatory bowel | 21 |
Copyright | |
44 other sections not shown
Common terms and phrases
acid active Crohn's disease acute adhesion molecules antibody antigens associated azathioprine bacterial budesonide cancer CD4+ T cells chronic Clin clinical colectomy colitis and Crohn's collagen colonic controlled trial corticosteroids Crohn's disease cyclosporine cytokines disease activity dose drugs dysplasia effect elemental diet endoscopic enemas expression fibroblasts fistulae function Gastroenterol Gastroenterology gastrointestinal gene genetic growth factor human IFN-y ileal ileostomy ileum immune Immunol increased induced inflammation inflammatory bowel disease inhibition integrins interleukin intestinal epithelial cells intestinal inflammation lamina propria lesions levels lymphocytes macrophages mast cells measles mediators mesalazine metabolism metronidazole mice mucosal normal oral pathogenesis patients with Crohn's patients with inflammatory patients with ulcerative peptide placebo pouch pouchitis prednisolone proctocolectomy production protein recent receptor recurrence relapse remission resection response risk role short bowel syndrome small bowel small intestine steroid stimulation studies sulphasalazine surgery therapeutic therapy tissue TNF-a treatment tumor necrosis ulcerative colitis